Some degree of depression affects at least 30% of hospitalized patients wit
h coronary artery disease (CAD), and is associated with increased risks of
mortality and continuing depression over at least the first year following
hospital discharge. Despite its consequences for prognosis and quality of l
ife, depression is underrecognized and undertreated in cardiac patients. Th
e diagnosis of depression is complicated in patients with medical illness.
Their symptoms can reflect physical as well as psychological complaints. Ma
ny CAD patients resist the idea of additional medications, and drug interac
tions can be problematic for those willing to accept antidepressant treatme
nt. Finally, depression tends to recur. Its successful treatment requires a
long-term commitment from both physician and patient. This article examine
s the special challenges involved in diagnosing depression in patients with
CAD. outlines available psychotherapeutic and pharmacological treatments,
and considers the issues involved in deciding which patients to treat, with
what approach, and for how long. (C) 2000 Elsevier Science Inc. All rights
reserved.